REGULATED PRESS RELEASE published on 04/30/2026 at 18:00, 5 months 22 days ago LABORATOIRES EUROMEDIS - RAPPORT FINANCIER ANNUEL 2025
BRIEF published on 04/24/2026 at 18:53, 5 months 28 days ago Euromedis Laboratories: 2025 Annual Results Revenue Gross Margin Positive EBITDA 2025 Results Outlook 2026
BRIEF published on 04/24/2026 at 18:53, 5 months 28 days ago Laboratoires Euromedis : Résultats Annuels 2025 Chiffre D'affaires Marge Brute Résultats 2025 Perspectives 2026 EBE Positif
REGULATED PRESS RELEASE published on 04/24/2026 at 18:48, 5 months 28 days ago Laboratoires Euromedis - Communiqué résultat 2025 Publication des résultats annuels 2025 avec une progression de l'activité et de la rentabilité. Perspectives 2026 sous incertitudes liées au contexte géopolitique. Prochains résultats semestriels fin octobre 2026 Résultats Annuels Euronext Growth Progression Incertitudes Perspectives 2026
BRIEF published on 03/26/2026 at 18:05, 6 months 27 days ago Fin du contrat de liquidité pour Laboratoires Euromedis Contrat De Liquidité Euronext Growth Gilbert Dupont Laboratoires Euromedis Simplification Financière
BRIEF published on 03/26/2026 at 18:05, 6 months 27 days ago End of the liquidity contract for Laboratoires Euromedis Liquidity Contract Euronext Growth Gilbert Dupont Euromedis Laboratories Financial Simplification
REGULATED PRESS RELEASE published on 03/26/2026 at 18:00, 6 months 27 days ago LABORATOIRES EUROMEDIS - Fin du contrat de liquidité Laboratoires Euromedis met fin à son contrat de liquidité avec Gilbert Dupont pour les actions cotées sur Euronext Growth, simplifiant ainsi ses opérations financières Contrat De Liquidité Euronext Growth Gilbert Dupont Laboratoires Euromedis Simplification Des Opérations Financières
BRIEF published on 10/31/2025 at 18:09, 11 months 22 days ago Laboratoires Euromedis - Résultats financiers semestriels 2025 Chiffre D'affaires Résultat Net Optimisation Des Coûts Mouvements Sociaux Ventes À L'export
BRIEF published on 10/31/2025 at 18:09, 11 months 22 days ago Euromedis Laboratories - 2025 Half-Year Financial Results Revenue Net Result Cost Optimization Export Sales Social Movements
REGULATED PRESS RELEASE published on 10/31/2025 at 18:04, 11 months 22 days ago LABORATOIRES EUROMEDIS - RAPPORT FINANCIER SEMESTRIEL 2025 SA Laboratoires Euromedis publie son rapport financier semestriel au 30 juin 2025, montrant une progression du chiffre d'affaires de 11% et un retour au positif du résultat net Chiffre D'affaires Rapport Financier Résultat Net SA Laboratoires Euromedis 30 Juin 2025
Published on 10/22/2026 at 16:00, 3 hours 38 minutes ago Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 5 hours 8 minutes ago Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components
Published on 10/22/2026 at 14:00, 5 hours 38 minutes ago Jericho Energy Ventures Amends Investor Relations Agreement with Orange Group Advisors
Published on 10/22/2026 at 14:00, 5 hours 38 minutes ago Viemed Healthcare Announces Third Quarter 2026 Earnings Conference Call Details
Published on 10/22/2026 at 13:45, 5 hours 53 minutes ago Karbon-X (OTCQB:KARX) Accelerates High-Margin Transformation in Q1 FY2027: Gross Margin Expands to 32%, Operating Cash Burn Drops 55%, and Deferred Revenue Reaches $4.3 Million
Published on 10/22/2026 at 18:45, 52 minutes ago Swedish Export Credit Corporation (SEK): Europe's defence build-up opens opportunities for Swedish companies in Germany
Published on 10/22/2026 at 18:30, 1 hour 8 minutes ago lePERMISLIBRE annonce l’organisation d’une visioconférence destinée aux actionnaires et investisseurs
Published on 10/22/2026 at 18:12, 1 hour 25 minutes ago LION E-Mobility AG: CEO Dr. Joachim Damasky to retire at the end of January 2027
Published on 10/22/2026 at 18:10, 1 hour 27 minutes ago EQS-Adhoc: LION E-Mobility AG: CEO Dr. Joachim Damasky to retire at the end of January 2027
Published on 10/22/2026 at 18:03, 1 hour 34 minutes ago Voltatron Strengthens Financial Foundation for Further Growth by Securing €14 Million Financing Package
Published on 10/22/2026 at 18:00, 1 hour 38 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 1 hour 38 minutes ago THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 1 hour 38 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
Published on 10/22/2026 at 18:00, 1 hour 38 minutes ago bioMérieux obtient l’autorisation 510(k) et la dérogation CLIA de la FDA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel : une avancée pour améliorer la santé des femmes grâce au diagnostic moléculaire rapide
Published on 10/22/2026 at 18:00, 1 hour 38 minutes ago 1er semestre 2026 : résultats opérationnels en nette amélioration
